Provasculon Company

Provasculon develops novel forms of stromal cell-derived factor-1 for the treatment of cardiovascular diseases and diabetic ulcers.


Investors

Founded Date: 2007-01-01
Last Funding Type: Debt Financing
Headquarters: Cambridge, Massachusetts, United States
Employee Number: 1-10
Industry: General Healthcare
Last Funding Date: 2011-11-09
Funding Status: Early Stage Venture
Total Funding: $7 250 000